Please use this identifier to cite or link to this item:
https://open.uns.ac.rs/handle/123456789/7856
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gorana Matovina-Brko | en_US |
dc.contributor.author | Maja Ružić | en_US |
dc.contributor.author | Milotka Fabri | en_US |
dc.contributor.author | Lazar Popović | en_US |
dc.contributor.author | Ivana Kolarov Bjelobrk | en_US |
dc.contributor.author | Jasna Trifunović | en_US |
dc.contributor.author | Danijela Petković | en_US |
dc.date.accessioned | 2019-09-30T09:04:52Z | - |
dc.date.available | 2019-09-30T09:04:52Z | - |
dc.date.issued | 2014-01-01 | - |
dc.identifier.issn | 1120009X | en_US |
dc.identifier.uri | https://open.uns.ac.rs/handle/123456789/7856 | - |
dc.description.abstract | Oncologists worldwide are often dealing with hepatitis C virus positive breast cancer patients, questioning adequate chemotherapy protocol, reduction of doses, delays, or even interruptions of treatment. We present a case of a woman in stage IIIB breast cancer, who after the completion of neoadjuvant treatment developed significant increase in liver enzymes and was diagnosed positive for HCV. She was treated with interferon and after the resolving of acute liver disease continued concomitant treatment with interferon, ribavirin, docetaxel, and trastuzumab. Grade 4 neutropenia and grade 3 hepatotoxicity occurred after the third cycle of chemo and 5 months of antiviral therapy. Interferon and chemotherapy were postponed for 1 week. There are no sufficient data in order to recommend the concomitant antiviral and antineoplastic therapy. Hepatitis C virus and antiviral therapy may increase the toxicities of antineoplastic treatment. However, when lifesaving oncologic treatment is necessary, concomitant antiviral therapy can be administered with more intensive follow up. © 2014 Edizioni Scientifiche per l'Informazione su Farmaci e Terapia. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Journal of Chemotherapy | en_US |
dc.subject | Breast cancer | en_US |
dc.subject | Docetaxel | en_US |
dc.subject | Hepatitis C virus | en_US |
dc.subject | Interferon | en_US |
dc.subject | Trastuzumab | en_US |
dc.title | Treatment of acute hepatitis c in breast cancer patient: A case report | en_US |
dc.type | Journal/Magazine Article | en_US |
dc.identifier.doi | 10.1179/1973947813Y.0000000129 | - |
dc.identifier.pmid | 26 | - |
dc.identifier.scopus | 2-s2.0-84900325343 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/84900325343 | - |
dc.description.version | Published | en_US |
dc.relation.lastpage | 183 | en_US |
dc.relation.firstpage | 180 | en_US |
dc.relation.issue | 3 | en_US |
dc.relation.volume | 26 | en_US |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
crisitem.author.dept | Medicinski fakultet, Katedra za infektivne bolesti | - |
crisitem.author.dept | Medicinski fakultet, Katedra za onkologiju | - |
crisitem.author.dept | Medicinski fakultet, Katedra za internu medicinu | - |
crisitem.author.dept | Medicinski fakultet, Katedra za internu medicinu | - |
crisitem.author.parentorg | Medicinski fakultet | - |
crisitem.author.parentorg | Medicinski fakultet | - |
crisitem.author.parentorg | Medicinski fakultet | - |
crisitem.author.parentorg | Medicinski fakultet | - |
Appears in Collections: | MDF Publikacije/Publications |
SCOPUSTM
Citations
3
checked on May 10, 2024
Page view(s)
29
Last Week
4
4
Last month
4
4
checked on May 10, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.